Diffusion-weighted MRI for quantification of liver fibrosis: Preliminary experience

American Journal of Roentgenology

Volumn 189, Issue 4, 2007, Pages 799-806

  Taouli, Bachir ^a   Tolia, Anuj J ^a   Losada, Mariela ^a   Babb, James S ^a   Chan, Edwin S ^a   Bannan, Michael A ^a   Tobias, Hillel ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cirrhosis; Diffusion; Fibrosis; Liver; MRI

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; FEMALE; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER; LIVER CIRRHOSIS; MALE; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 34748912281     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.2086     Document Type: Article

References (43)

1. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39:1147-1171
2. Kim AI, Saab S. Treatment of hepatitis C. Am J Med 2005; 118:808-815
3. Gish RG. Current treatment and future directions in the management of chronic hepatitis B viral infection. Clin Liver Dis 2005; 9:541-565
4. Janes CH, Lindor KD. Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med 1993; 118:96-98
5. Froehlich F, Lamy O, Fried M, Gonvers JJ. Practice and complications of liver biopsy: results of a nationwide survey in Switzerland. Dig Dis Sci 1993; 38:1480-1484
6. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology 2000; 32:477-481
7. Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1:523-525
8. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97:2614-2618
9. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38:1449-1457
10. Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K, Matsumoto T. Cirrhosis: modified caudateright lobe ratio. Radiology 2002; 224:769-774
11. Le Bihan D. Diffusion/perfusion MR imaging of the brain: from structure to function. Radiology 1990; 177:328-329
12. Namimoto T, Yamashita Y, Sumi S, Tang Y, Takahashi M. Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology 1997; 204:739-744
13. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR 1998; 170:397-402
14. Amano Y, Kumazaki T, Ishihara M. Single-shot diffusion-weighted echo-planar imaging of normal and cirrhotic livers using a phased-array multicoil. Acta Radiol 1998; 39:440-442
15. Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, Nakamura H. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR 1999; 173:393-398
16. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003; 226:71-78
17. Boulanger Y, AmaraM, LepantoL, et al. Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 2003; 16:132-136
18. Koinuma M, Ohashi I, Hanafusa K, Shibuya H. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 2005; 22:80-85
19. Murtz P, Flacke S, Traber F, van den Brink JS, Gieseke J, Schild HH. Abdomen: diffusion-weighted MR imaging with pulse-triggered single-shot sequences. Radiology 2002; 224:258-264
20. Taouli B, Martin AJ, Qayyum A, et al. Parallel imaging and diffusion tensor imaging for diffusion-weighted MRI of the liver: preliminary experience in healthy volunteers. AJR 2004; 183:677-680
21. Ito K, Mitchell DG. Hepatic morphologic changes in cirrhosis: MR imaging findings. Abdom Imaging 2000; 25:456-461
22. Ito K, Mitchell DG, Siegelman ES. Cirrhosis: MR imaging features. Magn Reson Imaging Clin N Am 2002; 10:75-92
23. Batts KP, Ludwig J. Chronic hepatitis: an update on terminology and reporting. Am J Surg Pathol 1995; 19:1409-1417
24. Kim WR. The burden of hepatitis C in the United States. Hepatology 2002; 36:S30-S34
25. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357:1069-1075
26. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24:289-293
27. Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology 2003; 38:481-492
28. Semelka RC, Chung JJ, Hussain SM, Marcos HB, Woosley JT. Chronic hepatitis: correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology - initial experience. J Magn Reson Imaging 2001; 13:385-391
29. Ito K, Mitchell DG, Gabata T. Enlargement of hilar periportal space: a sign of early cirrhosis at MR imaging. J Magn Reson Imaging 2000; 11:136-140
30. Ito K, Mitchell DG, Kim MJ, Awaya H, Koike S, Matsunaga N. Right posterior hepatic notch sign: a simple diagnostic MR finding of cirrhosis. J Magn Reson Imaging 2003; 18:561-566
31. Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 2006; 239:425-437
32. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41:48-54
33. Rouviere O, Yin M, Dresner MA, et al. MR elastography of the liver: preliminary Tesults. Radiology 2006; 240:440-448
34. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, FibroTest, APRI, and liver biopsy for the assessmentof fibrosis in chronic hepatitis C. Gastroenterology 2005; 128:343-350
35. Annet L, Materne R, Danse E, Jamart J, Horsmans Y Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003; 229:409-414
36. Hagiwara M, Rusinek H, Lee VS, et al. Quantification of liver fibrosis in patients with chronic liver disease using 3D perfusion-weighted MR imaging: preliminary experience. Radiology 2007 (in press)
37. Huwart L, Peeters F, Sinkus R, et al. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed 2006; 19:173-179
38. Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P, Van Beers BE. Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 2007; 25:122-128
39. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999; 210:617-623
40. Poynard T, Imbert-Bismut F, Munteanu M, et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004; 3:8
41. Bourliere M, Penaranda G, Renou C, et al. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat 2006; 13:659-670
42. Guido M, Fagiuoli S, Tessari G, et al. Histology predicts cirrhotic evolution of post transplant hepatitis C. Gut 2002; 50:697-700
43. Kumagai N, Kuramochi S, Toda K, et al. Assessment of histological features and outcome of interferon therapy in chronic hepatitis C. J Gastroenterol 1996; 31:69-74